Associations of handgrip strength with morbidity and all-cause mortality of cardiometabolic multimorbidity.
All-cause mortality
Cardiometabolic multimorbidity
Handgrip strength
UK Biobank
Journal
BMC medicine
ISSN: 1741-7015
Titre abrégé: BMC Med
Pays: England
ID NLM: 101190723
Informations de publication
Date de publication:
03 06 2022
03 06 2022
Historique:
received:
14
12
2021
accepted:
27
04
2022
entrez:
2
6
2022
pubmed:
3
6
2022
medline:
7
6
2022
Statut:
epublish
Résumé
Cardiometabolic multimorbidity (CM) is an increasing public health and clinical concern. However, predictors for the development and prognosis of CM are poorly understood. The aims of this study were to investigate the relation between handgrip strength (HGS) and the risk of CM and to examine the association of HGS with all-cause mortality risk among patients with CM. This prospective cohort study involved 493,774 participants from the UK Biobank. CM was defined as the simultaneous occurrence of two or more of the following conditions: type 2 diabetes, stroke, and coronary heart disease (CHD). Cox proportional hazards models were performed to estimate hazard ratios (HRs) and 95% confidence intervals (95% CIs). During a median follow-up of 12.1 years, 4701 incident CM cases were documented among participants with none cardiometabolic disease at baseline. Compared with the fourth quartile (Q4), the multivariable adjusted HR (95% CI) value of Q1 of HGS for developing CM was 1.46 (1.34-1.60). In participants with one cardiometabolic disease at baseline, participants in Q1 of HGS also possessed higher risk of CM than those in Q4, with HRs (95% CIs) being 1.35 (1.23-1.49) in patients with type 2 diabetes, 1.23 (1.04-1.46) in patients with stroke, and 1.23 (1.11-1.36) in patients with CHD. For participants with CM at recruitment, HGS was also associated with the risk of all-cause mortality (Q1 vs. Q4 HR: 1.57, 95% CI: 1.36-1.80). Our study provided novel evidence that HGS could be an independent predictor of morbidity and all-cause mortality of CM.
Sections du résumé
BACKGROUND
Cardiometabolic multimorbidity (CM) is an increasing public health and clinical concern. However, predictors for the development and prognosis of CM are poorly understood. The aims of this study were to investigate the relation between handgrip strength (HGS) and the risk of CM and to examine the association of HGS with all-cause mortality risk among patients with CM.
METHODS
This prospective cohort study involved 493,774 participants from the UK Biobank. CM was defined as the simultaneous occurrence of two or more of the following conditions: type 2 diabetes, stroke, and coronary heart disease (CHD). Cox proportional hazards models were performed to estimate hazard ratios (HRs) and 95% confidence intervals (95% CIs).
RESULTS
During a median follow-up of 12.1 years, 4701 incident CM cases were documented among participants with none cardiometabolic disease at baseline. Compared with the fourth quartile (Q4), the multivariable adjusted HR (95% CI) value of Q1 of HGS for developing CM was 1.46 (1.34-1.60). In participants with one cardiometabolic disease at baseline, participants in Q1 of HGS also possessed higher risk of CM than those in Q4, with HRs (95% CIs) being 1.35 (1.23-1.49) in patients with type 2 diabetes, 1.23 (1.04-1.46) in patients with stroke, and 1.23 (1.11-1.36) in patients with CHD. For participants with CM at recruitment, HGS was also associated with the risk of all-cause mortality (Q1 vs. Q4 HR: 1.57, 95% CI: 1.36-1.80).
CONCLUSIONS
Our study provided novel evidence that HGS could be an independent predictor of morbidity and all-cause mortality of CM.
Identifiants
pubmed: 35655218
doi: 10.1186/s12916-022-02389-y
pii: 10.1186/s12916-022-02389-y
pmc: PMC9164350
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
191Subventions
Organisme : Medical Research Council
ID : MC_PC_17228
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC_QA137853
Pays : United Kingdom
Informations de copyright
© 2022. The Author(s).
Références
J Gerontol A Biol Sci Med Sci. 2014 May;69(5):547-58
pubmed: 24737557
Mayo Clin Proc. 2020 May;95(5):879-888
pubmed: 32299669
Eur Heart J. 2014 Aug 14;35(31):2055-7
pubmed: 24950694
J Geriatr Phys Ther. 2015 Jul-Sep;38(3):115-21
pubmed: 25594523
BMJ. 2020 Feb 12;368:m131
pubmed: 32051121
Stroke. 2017 Jul;48(7):1818-1826
pubmed: 28526765
Sci Rep. 2017 Aug 1;7(1):7041
pubmed: 28765572
BMJ. 2018 May 8;361:k1651
pubmed: 29739772
BMJ. 1991 Aug 31;303(6801):523
pubmed: 1912874
Lancet. 2012 Jul 7;380(9836):37-43
pubmed: 22579043
BMJ Open. 2019 Mar 3;9(3):e024476
pubmed: 30833320
PLoS One. 2010 May 26;5(5):e10805
pubmed: 22421977
J Diabetes Complications. 2018 Oct;32(10):906-910
pubmed: 30121206
Diabetologia. 2011 Mar;54(3):523-6
pubmed: 21107522
J Gerontol A Biol Sci Med Sci. 2020 Sep 25;75(10):1974-1980
pubmed: 31406983
Med Sci Sports Exerc. 2000 Sep;32(9 Suppl):S498-504
pubmed: 10993420
Diabet Med. 2017 Aug;34(8):1120-1128
pubmed: 28144980
J Appl Physiol (1985). 2007 Sep;103(3):1093-8
pubmed: 17347387
Arq Bras Cardiol. 2007 Oct;89(4):256-62
pubmed: 17992383
Obesity (Silver Spring). 2020 Jul;28(7):1332-1341
pubmed: 32437090
Schizophr Bull. 2018 Jun 6;44(4):728-736
pubmed: 29684174
Am J Cardiol. 2020 Aug 15;129:5-9
pubmed: 32580913
Diabetes Care. 2017 Dec;40(12):1710-1718
pubmed: 28986505
Diabetologia. 2018 Jun;61(6):1241-1248
pubmed: 29247363
Circulation. 2018 Jun 12;137(24):2583-2591
pubmed: 29632216
BMC Public Health. 2019 Oct 24;19(1):1361
pubmed: 31651286
Lancet. 2015 Jul 18;386(9990):266-73
pubmed: 25982160
Ageing Res Rev. 2011 Sep;10(4):430-9
pubmed: 21402176
J Epidemiol Community Health. 2016 Dec;70(12):1214-1221
pubmed: 27229009
J Affect Disord. 2017 Oct 15;221:36-46
pubmed: 28628766
Prim Care Diabetes. 2021 Dec;15(6):1063-1070
pubmed: 34649825
Korean J Fam Med. 2020 Sep;41(5):291-298
pubmed: 32380799
Age Ageing. 2019 Sep 1;48(5):684-691
pubmed: 31204772
Diabetes Metab. 2019 Apr;45(2):209-211
pubmed: 28751101
J Appl Physiol (1985). 1998 Dec;85(6):2047-53
pubmed: 9843525
J Adv Res. 2017 Sep;8(5):537-548
pubmed: 28748119
Eur Heart J. 2017 Nov 14;38(43):3232-3240
pubmed: 29020281
Am J Prev Med. 2019 Jun;56(6):844-851
pubmed: 31003803
Diabetes Metab Res Rev. 2021 Feb;37(2):e3365
pubmed: 32543028
J Am Geriatr Soc. 2020 Jul;68(7):1438-1444
pubmed: 32633830
Clin Chim Acta. 2018 Sep;484:150-163
pubmed: 29803897
Lancet Public Health. 2017 May 19;2(6):e277-e285
pubmed: 28626830
PLoS Med. 2015 Mar 31;12(3):e1001779
pubmed: 25826379
J Gerontol A Biol Sci Med Sci. 2017 Oct 12;72(11):1525-1531
pubmed: 28329157
J Am Geriatr Soc. 2005 May;53(5):851-5
pubmed: 15877563
Curr Sports Med Rep. 2012 Jul-Aug;11(4):209-16
pubmed: 22777332
JAMA. 2015 Jul 7;314(1):52-60
pubmed: 26151266
Ann Med. 2020 May - Jun;52(3-4):109-119
pubmed: 32223654
Nature. 2008 Feb 7;451(7179):716-9
pubmed: 18204438
Lancet. 2007 Jun 16;369(9578):1980-1982
pubmed: 17574079
BMJ Open Diabetes Res Care. 2021 Aug;9(1):
pubmed: 34353878
Lancet. 2012 Mar 31;379(9822):1173-4
pubmed: 22463865
J Stroke Cerebrovasc Dis. 2003 May-Jun;12(3):119-26
pubmed: 17903915
Front Physiol. 2018 Feb 05;9:59
pubmed: 29459831